1. chem960
  2. 465-65-6
Naloxone | 465-65-6

제품 이름:Naloxone

CAS 번호:465-65-6
MF:C19H21NO4
메가와트:327.37
MDL:MFCD00242634
CID:37599
PubChem ID:5284596
소개
    纳洛酮(Naloxone)为**受体拮抗剂,口服无效,注射给药起效很快。主要用于**类药物过量中毒或用于**药成瘾的诊断。还用于**类复合麻醉药术后,解除呼吸抑制及催醒。
이름 및 식별자
  • Naloxone
  • (5alpha)-3,14-Dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one
  • (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
  • Naloxone solution
  • (5α)-4,5-Epoxy-3,14-dihydroxy-17-(2-propen-1-yl)morphinan-6-one
  • [14C]-Naloxone
  • [3H]-Naloxone
  • EN 1530 base
  • l-Naloxone
  • n-Allylnoroxymorphone
  • Nalone
  • Naloxona
  • Naloxonum
  • Narcan
  • Narcanti
  • Narcon
  • Naloxone, (controlled)
  • Naloxonum (Latin)
  • RAM-301
  • Q282902
  • naloxone
  • HY-17417A
  • N-Allyl-noroxymorphone
  • BIDD:GT0110
  • (4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
  • hydrochloride
  • EINECS 207-365-7
  • DTXCID703349
  • 17-Allyl-3,14-dihydroxy-4,5-alpha-epoxymorphinan-6-one
  • Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-
  • PDSP2_001520
  • BRN 1089071
  • NALOXONE [INN]
  • CS-0012343
  • NALOXONE [VANDF]
  • SCHEMBL34284
  • (5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one
  • NALOXONE [MI]
  • (5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propen-1-yl)morphinan-6-one
  • BSPBio_000122
  • BDBM579486
  • MLS000069540
  • Prestwick3_000111
  • GTPL1676
  • l-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
  • Prestwick1_000111
  • 1-N-Allyl-14-hydroxynordihydromorphinone
  • DBL Naloxone (TN)
  • SMR000058766
  • DB01183
  • UZHSEJADLWPNLE-GRGSLBFTSA-N
  • A06AH04
  • (-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one
  • BRD-K67511046-003-03-7
  • 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one
  • BDBM50000788
  • US11484525, Compound Naloxone
  • Prestwick0_000111
  • 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one (naloxone)
  • naloxoni hydrochloridum
  • 17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
  • NALOXONE [EMA EPAR]
  • 17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
  • 36B82AMQ7N
  • Tox21_112006_1
  • BPBio1_000136
  • 2-(([2-(ETHYLTHIO)-3-PYRIDYL]CARBONYL)AMINO)-4-(METHYLTHIO)BUTANOICACID
  • 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(Naxolone)
  • DTXSID8023349
  • Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy- (8CI)
  • Prestwick2_000111
  • Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-
  • (-)-Naloxone
  • NCGC00274058-01
  • (naloxone) 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • 4aH-8,5-bcd]furan-5(6H)-one, N-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-
  • 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone
  • NALOXONE [WHO-DD]
  • NALOXONE [USP-RS]
  • V03AB15
  • 4683B
  • 4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • NIOSH/QD2135000
  • CHEBI:7459
  • EN300-19748912
  • Morphinan-6-one, 4,5-alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-
  • NS00002914
  • Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-
  • NCGC00024674-03
  • Kloxxado (naloxone hydrochloride nasal spray)
  • NSC-70413
  • NSC70413
  • QD21350000
  • NALOXONE [HSDB]
  • 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one( Naloxone)
  • 17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
  • C07252
  • Naloxona [INN-Spanish]
  • Normorphinone, N-allyl-7,8-dihydro-14-hydroxy-, (-)-
  • (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
  • 17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one
  • 4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(naloxone)C2H2O4
  • Nyxoid
  • BDBM54795
  • Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- (9CI)
  • Naloxonum [INN-Latin]
  • UNII-36B82AMQ7N
  • HMS2090F20
  • Naloxone [INN:BAN]
  • N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon
  • (naloxone)4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • Normorphinone, N-allyl-dihydro-14-hydroxy-
  • AKOS016009988
  • l-N-Allyl-14-hydroxynordihydromorphinone
  • (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
  • hydrochloride
  • Naloxonum (INN-Latin)
  • 1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
  • Tox21_112006
  • 465-65-6
  • Naloxone (INN)
  • (4R,4aS,7aR,12bS)-4a,9-bis(oxidanyl)-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
  • hydrochloride
  • Morphinan-6-one,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-
  • (5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one
  • NCGC00162267-02
  • NALOXONE [ORANGE BOOK]
  • (naloxone)4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • NALOXONE (USP-RS)
  • CAS-465-65-6
  • NSC 70413
  • MORPHINAN-6-ONE, 4,5-EPOXY-3,14-DIHYDROXY-17-(2-PROPENYL)-
  • NLX
  • Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-17-(2-propenyl)-
  • BRD-K67511046-001-02-3
  • NCGC00024674-02
  • SMP1_000205
  • Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-
  • Naloxone Nasal Spray
  • (-)-N-ALLYL-14-HYDROXYNORDIHYDROMORPHINONE
  • CHEMBL80
  • Morphinan-6-one, 17-allyl-3,14-dihydroxy-4,5-alpha-epoxy-
  • GTPL1638
  • cid_5464092
  • Normorphinone, 7,8-dihydro-N-allyl-14-hydroxy-
  • SPBio_002061
  • D08249
  • (1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one
  • HSDB 3279
  • Naloxona (INN-Spanish)
  • 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-
  • [17-(2,3-3H-2-propenyl)]-4, 5a -epoxy-3,14-dihydroxymorphinan-6-one
  • 7,8-Dihydro-N-allyl-14-hydroxynormorphinone
  • [3H]naloxone
  • DBL Naloxone
  • MLS000736771
  • Nalossone
  • 3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one
  • [N-allyl-2,3-3H]naloxone
  • Nalossone [DCIT]
  • MDL:MFCD00242634
  • InChIKey:UZHSEJADLWPNLE-GRGSLBFTSA-N
  • Inchi:InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1
  • SMILES:C=CCN1CC[C@@]23C4=C5C=CC(=C4O[C@H]3C(=O)CC[C@]2([C@H]1C5)O)O
화학적 및 물리적 성질

계산된 속성

  • 정밀분자량: 327.4g/mol
  • 표면전하: 0
  • XLogP3: 2.1
  • 수소 결합 공급체 수량: 2
  • 수소 결합 수용체 수량: 5
  • 회전 가능한 화학 키 수량: 2
  • 동위원소 질량: 327.147058g/mol
  • 단일 동위원소 질량: 327.147058g/mol
  • 수소 결합 토폴로지 분자 극성 표면적: 70Ų
  • 중원자 수량: 24
  • 복잡도: 594
  • 동위원소 원자 수량: 0
  • 원자 구조의 중심 수량을 확정하다.: 4
  • 정의되지 않은 원자 구성 센터 수: 0
  • 화학 키 입체 구조의 중심 수량을 확정하다.: 0
  • 불확정 화학 키 입체 중심 수량: 0
  • 총 키 단위 수량: 1
  • 토폴로지 테이블 영역: 70
  • 동위원소 원자 계수: 0
  • 상호 변형 이기종 수량: 6
  • 소수점 매개변수 계산 참조값(XLogP3-AA): 2.1
  • 표면전하: 0

실험적 성질

  • 분해 하 다.: When heated to decomposition it emits toxic fumes of /nitrogen oxides/.
  • 해리 상수:pKa1 = 7.84 (amine); pKa2 = 10.07 (phenol); pKa3 = 13.58 (hydroxy) (est)
  • LogP: 1.23930
  • PSA: 70.00000
  • 굴절률: 1.5000 (estimate)
  • 비등점: 465.27°C (rough estimate)
  • 플래시 포인트: 276.1ºC
  • 안정성: Not particularly hygroscopic; can oxidize; relatively stable in heat hydrochloride
  • 비선광도: D20 -194.5° (c = 0.93 in CHCl3)
  • 밀도: 1.2223 (rough estimate)
보안 정보
  • 기호: GHS07
  • WGK 독일:3
  • 보안 지침:S26: 눈에 닿으면 즉시 많은 양의 물로 씻어 의사에게 보내 치료한다.
  • 위험물 표시: F F T T
  • 위험물 운송번호:NONH for all modes of transport
  • 피해 선언:H302-H315-H319-H335
  • 경고성 성명:P301+P312+P330-P305+P351+P338
  • 저장 조건:빛이 너무 많은 것을 방지하기 위해서는 과도한 습기와 공기의 접촉으로부터 보호해야 한다.저장 온도가 30 ° C 보다 낮다
  • 위험 범주 코드:R36/37/38: 눈, 호흡기 및 피부 자극
  • 신호어:Warning
관련 문헌
관련 제품
사용 가능한 가격 데이터
브랜드:scbt 공급업체:圣克鲁斯生物技术
아니요. 순결 주식 사양 가격 업데이트 시간 가동
sc-477809-200mg 200mg ¥2256.00 05 Sep. 2023
sc-477809-200 mg 200mg ¥2,256.00 11 Jul. 2023
브랜드:Key Organics 공급업체:Key Organics Ltd
아니요. 순결 주식 사양 가격 업데이트 시간 가동
KS-5379-10MG >97% Same Day Despatch 10mg £51.00/ ¥425.04 07 Sep. 2023
KS-5379-5MG >97% Same Day Despatch 5mg £42.00/ ¥350.04 07 Sep. 2023
KS-5379-1MG >97% Same Day Despatch 1mg £36.00/ ¥300.03 07 Sep. 2023
브랜드:sigmaaldrich 공급업체:西格玛奥德里奇(上海)贸易有限公司
아니요. 순결 주식 사양 가격 업데이트 시간 가동
N-004-1ML 1ML ¥461.21 17 Jan. 2023
N-004-1ML 1ml ¥461.21 01 May. 2023
브랜드:biosynth 공급업체:Biosynth
아니요. 순결 주식 사양 가격 업데이트 시간 가동
FN61467-25 mg Please enquire 25mg $346.50/ ¥2,516.70 04 Jan. 2023
FN61467-10 mg Please enquire 10mg $231.00/ ¥1,677.80 04 Jan. 2023
FN61467-5 mg Please enquire 5mg $144.40/ ¥1,048.81 04 Jan. 2023
FN61467-2 mg Please enquire 2mg $92.40/ ¥671.12 04 Jan. 2023
FN61467-1 mg Please enquire 1mg $57.75/ ¥419.45 04 Jan. 2023
브랜드:trc 공급업체:TRC
아니요. 순결 주식 사양 가격 업데이트 시간 가동
N284995-1g 0.0 1g $1618.00/ ¥11,751.86 17 May. 2023
N284995-250mg 0.0 250mg $696.00/ ¥5,055.19 17 May. 2023
N284995-100mg 0.0 100mg $ 357.00/ ¥2,592.96 06 Sep. 2023
N284995-10mg 0.0 10mg $ 155.00/ ¥1,125.80 06 Sep. 2023
N284995-5mg 0.0 5mg $125.00/ ¥907.90 17 May. 2023
N284995-1mg 0.0 1mg $ 68.00/ ¥493.90 06 Sep. 2023
브랜드:enaminestore 공급업체:Enamine
아니요. 순결 주식 사양 가격 업데이트 시간 가동
EN300-19748912-0.05g Out of Stock 0.05g $636.0/ ¥4,619.40 16 Sep. 2023
이상의 데이터는 모두 인터넷에서 유래한 것이다.개인 정보가 침해되는 경우 가능한 한 빨리 연락 주시기 바랍니다 (귀사의 이메일 사본을 남기십시오). 저희는 이를 기록해서 처리할 것입니다!불편을 드려 죄송합니다!
©2008-2024 chem960.com 모든 권리를 보유하다